{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:13:15Z","timestamp":1783181595878,"version":"3.54.6"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,29]]},"DOI":"10.7759\/cureus.20004","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T16:40:46Z","timestamp":1638204046000},"source":"Crossref","is-referenced-by-count":7,"title":["Metastatic Porocarcinoma Effectively Managed by Pembrolizumab"],"prefix":"10.7759","author":[{"given":"Arminder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Everest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Vinogradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001566","article-title":"Eccrine porocarcinoma: new insights and a systematic review of the literature","volume":"44","author":"Nazemi A","year":"2018","unstructured":"Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg. 2018, 44:1247-61. 10.1097\/DSS.0000000000001566","journal-title":"Dermatol Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26178","article-title":"Eccrine porocarcinoma of the head and neck: meta-analysis of 120 cases","volume":"42","author":"Le NS","year":"2020","unstructured":"Le NS, Janik S, Liu DT, et al.. Eccrine porocarcinoma of the head and neck: meta-analysis of 120 cases. Head Neck. 2020, 42:2644-59. 10.1002\/hed.26178","journal-title":"Head Neck"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2017.06.027","article-title":"Porocarcinoma; presentation and management, a meta-analysis of 453 cases","volume":"20","author":"Salih AM","year":"2017","unstructured":"Salih AM, Kakamad FH, Baba HO, et al.. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann Med Surg (Lond). 2017, 20:74-9. 10.1016\/j.amsu.2017.06.027","journal-title":"Ann Med Surg (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1199310","article-title":"Pembrolizumab (Keytruda)","volume":"12","author":"Kwok G","year":"2016","unstructured":"Kwok G, Yau TC, Chiu JW, Tse E, Kwong YL. Pembrolizumab (Keytruda). Hum Vaccin Immunother. 2016, 12:2777-89. 10.1080\/21645515.2016.1199310","journal-title":"Hum Vaccin Immunother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000448073","article-title":"Metastatic eccrine porocarcinoma: a rare case of successful treatment","volume":"9","author":"Mandaliya H","year":"2016","unstructured":"Mandaliya H, Nordman I. Metastatic eccrine porocarcinoma: a rare case of successful treatment. Case Rep Oncol. 2016, 9:454-6. 10.1159\/000448073","journal-title":"Case Rep Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/282536","article-title":"Successful management of metastatic eccrine porocarcinoma","volume":"2013","author":"Aaribi I","year":"2013","unstructured":"Aaribi I, Mohtaram A, Ben Ameur El Youbi M, et al.. Successful management of metastatic eccrine porocarcinoma. Case Rep Oncol Med. 2013, 2013:282536. 10.1155\/2013\/282536","journal-title":"Case Rep Oncol Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12830","article-title":"Successful treatment of porocarcinoma with maxacalcitol and imiquimod","volume":"32","author":"Nagasawa T","year":"2019","unstructured":"Nagasawa T, Hirata A, Niiyama S, Enomoto Y, Fukuda H. Successful treatment of porocarcinoma with maxacalcitol and imiquimod. Dermatol Ther. 2019, 32:e12830. 10.1111\/dth.12830","journal-title":"Dermatol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228917","article-title":"Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab","volume":"12","author":"Lee KA","year":"2019","unstructured":"Lee KA, Cioni M, Robson A, Bataille V. Metastatic porocarcinoma achieving complete radiological and clinical response with pembrolizumab. BMJ Case Rep. 2019, 12:e228917. 10.1136\/bcr-2018-228917","journal-title":"BMJ Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78422-metastatic-porocarcinoma-effectively-managed-by-pembrolizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:14Z","timestamp":1707507134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78422-metastatic-porocarcinoma-effectively-managed-by-pembrolizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.20004","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,29]]}}}